The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Antibody Therapeutics and Blood Antibody Therapeutics Market Research Report 2024
Synopsis
Antibody, also called immunoglobulin, a protective protein produced by the immune system in response to the presence of a foreign substance, called an antigen. Antibodies recognize and latch onto antigens in order to remove them from the body. A wide range of substances are regarded by the body as antigens, including disease-causing organisms and toxic materials such as insect venom.
Treatment that uses antibodies to help the body fight cancer, infection, or other diseases. Antibodies are proteins made by the immune system that bind to specific markers on cells or tissues. IgG1 antibodies are a type of antibody made in the laboratory that can be used in diagnosis or treatment. In cancer treatment, IgG1 antibodies may kill cancer cells directly, they may block development of tumor blood vessels, or they may help the immune system kill cancer cells.
The global Antibody Therapeutics and Blood Antibody Therapeutics market was valued at US$ 191410 million in 2023 and is anticipated to reach US$ 373470 million by 2030, witnessing a CAGR of 9.9% during the forecast period 2024-2030.
The industry's leading producers are Roche, Abbvie and J & J, with revenues of 15.61%, 12.10% and 10.05% in 2019.
This report aims to provide a comprehensive presentation of the global market for Antibody Therapeutics and Blood Antibody Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antibody Therapeutics and Blood Antibody Therapeutics.
Report Scope
The Antibody Therapeutics and Blood Antibody Therapeutics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Antibody Therapeutics and Blood Antibody Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Antibody Therapeutics and Blood Antibody Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Roche
Abbvie
Johnson & Johnson
Bristol-Myers Squibb
Novartis
Merck
Alexion Pharmaceuticals
Takeda
Amgen
Biogen
UCB
Eli Lilly and Company
AstraZeneca
Segment by Type
IgG1
IgG4
Others
Segment by Application
Autoimmune
Tumor
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Antibody Therapeutics and Blood Antibody Therapeutics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Antibody, also called immunoglobulin, a protective protein produced by the immune system in response to the presence of a foreign substance, called an antigen. Antibodies recognize and latch onto antigens in order to remove them from the body. A wide range of substances are regarded by the body as antigens, including disease-causing organisms and toxic materials such as insect venom.
Treatment that uses antibodies to help the body fight cancer, infection, or other diseases. Antibodies are proteins made by the immune system that bind to specific markers on cells or tissues. IgG1 antibodies are a type of antibody made in the laboratory that can be used in diagnosis or treatment. In cancer treatment, IgG1 antibodies may kill cancer cells directly, they may block development of tumor blood vessels, or they may help the immune system kill cancer cells.
The global Antibody Therapeutics and Blood Antibody Therapeutics market was valued at US$ 191410 million in 2023 and is anticipated to reach US$ 373470 million by 2030, witnessing a CAGR of 9.9% during the forecast period 2024-2030.
The industry's leading producers are Roche, Abbvie and J & J, with revenues of 15.61%, 12.10% and 10.05% in 2019.
This report aims to provide a comprehensive presentation of the global market for Antibody Therapeutics and Blood Antibody Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antibody Therapeutics and Blood Antibody Therapeutics.
Report Scope
The Antibody Therapeutics and Blood Antibody Therapeutics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Antibody Therapeutics and Blood Antibody Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Antibody Therapeutics and Blood Antibody Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Roche
Abbvie
Johnson & Johnson
Bristol-Myers Squibb
Novartis
Merck
Alexion Pharmaceuticals
Takeda
Amgen
Biogen
UCB
Eli Lilly and Company
AstraZeneca
Segment by Type
IgG1
IgG4
Others
Segment by Application
Autoimmune
Tumor
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Antibody Therapeutics and Blood Antibody Therapeutics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Antibody Therapeutics and Blood Antibody Therapeutics Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 IgG1
1.2.3 IgG4
1.2.4 Others
1.3 Market by Application
1.3.1 Global Antibody Therapeutics and Blood Antibody Therapeutics Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Autoimmune
1.3.3 Tumor
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Antibody Therapeutics and Blood Antibody Therapeutics Market Perspective (2019-2030)
2.2 Antibody Therapeutics and Blood Antibody Therapeutics Growth Trends by Region
2.2.1 Global Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Antibody Therapeutics and Blood Antibody Therapeutics Historic Market Size by Region (2019-2024)
2.2.3 Antibody Therapeutics and Blood Antibody Therapeutics Forecasted Market Size by Region (2025-2030)
2.3 Antibody Therapeutics and Blood Antibody Therapeutics Market Dynamics
2.3.1 Antibody Therapeutics and Blood Antibody Therapeutics Industry Trends
2.3.2 Antibody Therapeutics and Blood Antibody Therapeutics Market Drivers
2.3.3 Antibody Therapeutics and Blood Antibody Therapeutics Market Challenges
2.3.4 Antibody Therapeutics and Blood Antibody Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Antibody Therapeutics and Blood Antibody Therapeutics Players by Revenue
3.1.1 Global Top Antibody Therapeutics and Blood Antibody Therapeutics Players by Revenue (2019-2024)
3.1.2 Global Antibody Therapeutics and Blood Antibody Therapeutics Revenue Market Share by Players (2019-2024)
3.2 Global Antibody Therapeutics and Blood Antibody Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Antibody Therapeutics and Blood Antibody Therapeutics Revenue
3.4 Global Antibody Therapeutics and Blood Antibody Therapeutics Market Concentration Ratio
3.4.1 Global Antibody Therapeutics and Blood Antibody Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Antibody Therapeutics and Blood Antibody Therapeutics Revenue in 2023
3.5 Antibody Therapeutics and Blood Antibody Therapeutics Key Players Head office and Area Served
3.6 Key Players Antibody Therapeutics and Blood Antibody Therapeutics Product Solution and Service
3.7 Date of Enter into Antibody Therapeutics and Blood Antibody Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Antibody Therapeutics and Blood Antibody Therapeutics Breakdown Data by Type
4.1 Global Antibody Therapeutics and Blood Antibody Therapeutics Historic Market Size by Type (2019-2024)
4.2 Global Antibody Therapeutics and Blood Antibody Therapeutics Forecasted Market Size by Type (2025-2030)
5 Antibody Therapeutics and Blood Antibody Therapeutics Breakdown Data by Application
5.1 Global Antibody Therapeutics and Blood Antibody Therapeutics Historic Market Size by Application (2019-2024)
5.2 Global Antibody Therapeutics and Blood Antibody Therapeutics Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Antibody Therapeutics and Blood Antibody Therapeutics Market Size (2019-2030)
6.2 North America Antibody Therapeutics and Blood Antibody Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Country (2019-2024)
6.4 North America Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Antibody Therapeutics and Blood Antibody Therapeutics Market Size (2019-2030)
7.2 Europe Antibody Therapeutics and Blood Antibody Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Country (2019-2024)
7.4 Europe Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Antibody Therapeutics and Blood Antibody Therapeutics Market Size (2019-2030)
8.2 Asia-Pacific Antibody Therapeutics and Blood Antibody Therapeutics Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Region (2019-2024)
8.4 Asia-Pacific Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Antibody Therapeutics and Blood Antibody Therapeutics Market Size (2019-2030)
9.2 Latin America Antibody Therapeutics and Blood Antibody Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Country (2019-2024)
9.4 Latin America Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Antibody Therapeutics and Blood Antibody Therapeutics Market Size (2019-2030)
10.2 Middle East & Africa Antibody Therapeutics and Blood Antibody Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Country (2019-2024)
10.4 Middle East & Africa Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Roche
11.1.1 Roche Company Detail
11.1.2 Roche Business Overview
11.1.3 Roche Antibody Therapeutics and Blood Antibody Therapeutics Introduction
11.1.4 Roche Revenue in Antibody Therapeutics and Blood Antibody Therapeutics Business (2019-2024)
11.1.5 Roche Recent Development
11.2 Abbvie
11.2.1 Abbvie Company Detail
11.2.2 Abbvie Business Overview
11.2.3 Abbvie Antibody Therapeutics and Blood Antibody Therapeutics Introduction
11.2.4 Abbvie Revenue in Antibody Therapeutics and Blood Antibody Therapeutics Business (2019-2024)
11.2.5 Abbvie Recent Development
11.3 Johnson & Johnson
11.3.1 Johnson & Johnson Company Detail
11.3.2 Johnson & Johnson Business Overview
11.3.3 Johnson & Johnson Antibody Therapeutics and Blood Antibody Therapeutics Introduction
11.3.4 Johnson & Johnson Revenue in Antibody Therapeutics and Blood Antibody Therapeutics Business (2019-2024)
11.3.5 Johnson & Johnson Recent Development
11.4 Bristol-Myers Squibb
11.4.1 Bristol-Myers Squibb Company Detail
11.4.2 Bristol-Myers Squibb Business Overview
11.4.3 Bristol-Myers Squibb Antibody Therapeutics and Blood Antibody Therapeutics Introduction
11.4.4 Bristol-Myers Squibb Revenue in Antibody Therapeutics and Blood Antibody Therapeutics Business (2019-2024)
11.4.5 Bristol-Myers Squibb Recent Development
11.5 Novartis
11.5.1 Novartis Company Detail
11.5.2 Novartis Business Overview
11.5.3 Novartis Antibody Therapeutics and Blood Antibody Therapeutics Introduction
11.5.4 Novartis Revenue in Antibody Therapeutics and Blood Antibody Therapeutics Business (2019-2024)
11.5.5 Novartis Recent Development
11.6 Merck
11.6.1 Merck Company Detail
11.6.2 Merck Business Overview
11.6.3 Merck Antibody Therapeutics and Blood Antibody Therapeutics Introduction
11.6.4 Merck Revenue in Antibody Therapeutics and Blood Antibody Therapeutics Business (2019-2024)
11.6.5 Merck Recent Development
11.7 Alexion Pharmaceuticals
11.7.1 Alexion Pharmaceuticals Company Detail
11.7.2 Alexion Pharmaceuticals Business Overview
11.7.3 Alexion Pharmaceuticals Antibody Therapeutics and Blood Antibody Therapeutics Introduction
11.7.4 Alexion Pharmaceuticals Revenue in Antibody Therapeutics and Blood Antibody Therapeutics Business (2019-2024)
11.7.5 Alexion Pharmaceuticals Recent Development
11.8 Takeda
11.8.1 Takeda Company Detail
11.8.2 Takeda Business Overview
11.8.3 Takeda Antibody Therapeutics and Blood Antibody Therapeutics Introduction
11.8.4 Takeda Revenue in Antibody Therapeutics and Blood Antibody Therapeutics Business (2019-2024)
11.8.5 Takeda Recent Development
11.9 Amgen
11.9.1 Amgen Company Detail
11.9.2 Amgen Business Overview
11.9.3 Amgen Antibody Therapeutics and Blood Antibody Therapeutics Introduction
11.9.4 Amgen Revenue in Antibody Therapeutics and Blood Antibody Therapeutics Business (2019-2024)
11.9.5 Amgen Recent Development
11.10 Biogen
11.10.1 Biogen Company Detail
11.10.2 Biogen Business Overview
11.10.3 Biogen Antibody Therapeutics and Blood Antibody Therapeutics Introduction
11.10.4 Biogen Revenue in Antibody Therapeutics and Blood Antibody Therapeutics Business (2019-2024)
11.10.5 Biogen Recent Development
11.11 UCB
11.11.1 UCB Company Detail
11.11.2 UCB Business Overview
11.11.3 UCB Antibody Therapeutics and Blood Antibody Therapeutics Introduction
11.11.4 UCB Revenue in Antibody Therapeutics and Blood Antibody Therapeutics Business (2019-2024)
11.11.5 UCB Recent Development
11.12 Eli Lilly and Company
11.12.1 Eli Lilly and Company Company Detail
11.12.2 Eli Lilly and Company Business Overview
11.12.3 Eli Lilly and Company Antibody Therapeutics and Blood Antibody Therapeutics Introduction
11.12.4 Eli Lilly and Company Revenue in Antibody Therapeutics and Blood Antibody Therapeutics Business (2019-2024)
11.12.5 Eli Lilly and Company Recent Development
11.13 AstraZeneca
11.13.1 AstraZeneca Company Detail
11.13.2 AstraZeneca Business Overview
11.13.3 AstraZeneca Antibody Therapeutics and Blood Antibody Therapeutics Introduction
11.13.4 AstraZeneca Revenue in Antibody Therapeutics and Blood Antibody Therapeutics Business (2019-2024)
11.13.5 AstraZeneca Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Antibody Therapeutics and Blood Antibody Therapeutics Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of IgG1
Table 3. Key Players of IgG4
Table 4. Key Players of Others
Table 5. Global Antibody Therapeutics and Blood Antibody Therapeutics Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Region (2019-2024) & (US$ Million)
Table 8. Global Antibody Therapeutics and Blood Antibody Therapeutics Market Share by Region (2019-2024)
Table 9. Global Antibody Therapeutics and Blood Antibody Therapeutics Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 10. Global Antibody Therapeutics and Blood Antibody Therapeutics Market Share by Region (2025-2030)
Table 11. Antibody Therapeutics and Blood Antibody Therapeutics Market Trends
Table 12. Antibody Therapeutics and Blood Antibody Therapeutics Market Drivers
Table 13. Antibody Therapeutics and Blood Antibody Therapeutics Market Challenges
Table 14. Antibody Therapeutics and Blood Antibody Therapeutics Market Restraints
Table 15. Global Antibody Therapeutics and Blood Antibody Therapeutics Revenue by Players (2019-2024) & (US$ Million)
Table 16. Global Antibody Therapeutics and Blood Antibody Therapeutics Market Share by Players (2019-2024)
Table 17. Global Top Antibody Therapeutics and Blood Antibody Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antibody Therapeutics and Blood Antibody Therapeutics as of 2023)
Table 18. Ranking of Global Top Antibody Therapeutics and Blood Antibody Therapeutics Companies by Revenue (US$ Million) in 2023
Table 19. Global 5 Largest Players Market Share by Antibody Therapeutics and Blood Antibody Therapeutics Revenue (CR5 and HHI) & (2019-2024)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Antibody Therapeutics and Blood Antibody Therapeutics Product Solution and Service
Table 22. Date of Enter into Antibody Therapeutics and Blood Antibody Therapeutics Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Type (2019-2024) & (US$ Million)
Table 25. Global Antibody Therapeutics and Blood Antibody Therapeutics Revenue Market Share by Type (2019-2024)
Table 26. Global Antibody Therapeutics and Blood Antibody Therapeutics Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 27. Global Antibody Therapeutics and Blood Antibody Therapeutics Revenue Market Share by Type (2025-2030)
Table 28. Global Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Application (2019-2024) & (US$ Million)
Table 29. Global Antibody Therapeutics and Blood Antibody Therapeutics Revenue Market Share by Application (2019-2024)
Table 30. Global Antibody Therapeutics and Blood Antibody Therapeutics Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 31. Global Antibody Therapeutics and Blood Antibody Therapeutics Revenue Market Share by Application (2025-2030)
Table 32. North America Antibody Therapeutics and Blood Antibody Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 33. North America Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Country (2019-2024) & (US$ Million)
Table 34. North America Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Country (2025-2030) & (US$ Million)
Table 35. Europe Antibody Therapeutics and Blood Antibody Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. Europe Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Country (2019-2024) & (US$ Million)
Table 37. Europe Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Country (2025-2030) & (US$ Million)
Table 38. Asia-Pacific Antibody Therapeutics and Blood Antibody Therapeutics Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 39. Asia-Pacific Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Region (2019-2024) & (US$ Million)
Table 40. Asia-Pacific Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Region (2025-2030) & (US$ Million)
Table 41. Latin America Antibody Therapeutics and Blood Antibody Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 42. Latin America Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Country (2019-2024) & (US$ Million)
Table 43. Latin America Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Country (2025-2030) & (US$ Million)
Table 44. Middle East & Africa Antibody Therapeutics and Blood Antibody Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 45. Middle East & Africa Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Country (2019-2024) & (US$ Million)
Table 46. Middle East & Africa Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Country (2025-2030) & (US$ Million)
Table 47. Roche Company Detail
Table 48. Roche Business Overview
Table 49. Roche Antibody Therapeutics and Blood Antibody Therapeutics Product
Table 50. Roche Revenue in Antibody Therapeutics and Blood Antibody Therapeutics Business (2019-2024) & (US$ Million)
Table 51. Roche Recent Development
Table 52. Abbvie Company Detail
Table 53. Abbvie Business Overview
Table 54. Abbvie Antibody Therapeutics and Blood Antibody Therapeutics Product
Table 55. Abbvie Revenue in Antibody Therapeutics and Blood Antibody Therapeutics Business (2019-2024) & (US$ Million)
Table 56. Abbvie Recent Development
Table 57. Johnson & Johnson Company Detail
Table 58. Johnson & Johnson Business Overview
Table 59. Johnson & Johnson Antibody Therapeutics and Blood Antibody Therapeutics Product
Table 60. Johnson & Johnson Revenue in Antibody Therapeutics and Blood Antibody Therapeutics Business (2019-2024) & (US$ Million)
Table 61. Johnson & Johnson Recent Development
Table 62. Bristol-Myers Squibb Company Detail
Table 63. Bristol-Myers Squibb Business Overview
Table 64. Bristol-Myers Squibb Antibody Therapeutics and Blood Antibody Therapeutics Product
Table 65. Bristol-Myers Squibb Revenue in Antibody Therapeutics and Blood Antibody Therapeutics Business (2019-2024) & (US$ Million)
Table 66. Bristol-Myers Squibb Recent Development
Table 67. Novartis Company Detail
Table 68. Novartis Business Overview
Table 69. Novartis Antibody Therapeutics and Blood Antibody Therapeutics Product
Table 70. Novartis Revenue in Antibody Therapeutics and Blood Antibody Therapeutics Business (2019-2024) & (US$ Million)
Table 71. Novartis Recent Development
Table 72. Merck Company Detail
Table 73. Merck Business Overview
Table 74. Merck Antibody Therapeutics and Blood Antibody Therapeutics Product
Table 75. Merck Revenue in Antibody Therapeutics and Blood Antibody Therapeutics Business (2019-2024) & (US$ Million)
Table 76. Merck Recent Development
Table 77. Alexion Pharmaceuticals Company Detail
Table 78. Alexion Pharmaceuticals Business Overview
Table 79. Alexion Pharmaceuticals Antibody Therapeutics and Blood Antibody Therapeutics Product
Table 80. Alexion Pharmaceuticals Revenue in Antibody Therapeutics and Blood Antibody Therapeutics Business (2019-2024) & (US$ Million)
Table 81. Alexion Pharmaceuticals Recent Development
Table 82. Takeda Company Detail
Table 83. Takeda Business Overview
Table 84. Takeda Antibody Therapeutics and Blood Antibody Therapeutics Product
Table 85. Takeda Revenue in Antibody Therapeutics and Blood Antibody Therapeutics Business (2019-2024) & (US$ Million)
Table 86. Takeda Recent Development
Table 87. Amgen Company Detail
Table 88. Amgen Business Overview
Table 89. Amgen Antibody Therapeutics and Blood Antibody Therapeutics Product
Table 90. Amgen Revenue in Antibody Therapeutics and Blood Antibody Therapeutics Business (2019-2024) & (US$ Million)
Table 91. Amgen Recent Development
Table 92. Biogen Company Detail
Table 93. Biogen Business Overview
Table 94. Biogen Antibody Therapeutics and Blood Antibody Therapeutics Product
Table 95. Biogen Revenue in Antibody Therapeutics and Blood Antibody Therapeutics Business (2019-2024) & (US$ Million)
Table 96. Biogen Recent Development
Table 97. UCB Company Detail
Table 98. UCB Business Overview
Table 99. UCB Antibody Therapeutics and Blood Antibody Therapeutics Product
Table 100. UCB Revenue in Antibody Therapeutics and Blood Antibody Therapeutics Business (2019-2024) & (US$ Million)
Table 101. UCB Recent Development
Table 102. Eli Lilly and Company Company Detail
Table 103. Eli Lilly and Company Business Overview
Table 104. Eli Lilly and Company Antibody Therapeutics and Blood Antibody Therapeutics Product
Table 105. Eli Lilly and Company Revenue in Antibody Therapeutics and Blood Antibody Therapeutics Business (2019-2024) & (US$ Million)
Table 106. Eli Lilly and Company Recent Development
Table 107. AstraZeneca Company Detail
Table 108. AstraZeneca Business Overview
Table 109. AstraZeneca Antibody Therapeutics and Blood Antibody Therapeutics Product
Table 110. AstraZeneca Revenue in Antibody Therapeutics and Blood Antibody Therapeutics Business (2019-2024) & (US$ Million)
Table 111. AstraZeneca Recent Development
Table 112. Research Programs/Design for This Report
Table 113. Key Data Information from Secondary Sources
Table 114. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Antibody Therapeutics and Blood Antibody Therapeutics Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Antibody Therapeutics and Blood Antibody Therapeutics Market Share by Type: 2023 VS 2030
Figure 3. IgG1 Features
Figure 4. IgG4 Features
Figure 5. Others Features
Figure 6. Global Antibody Therapeutics and Blood Antibody Therapeutics Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Antibody Therapeutics and Blood Antibody Therapeutics Market Share by Application: 2023 VS 2030
Figure 8. Autoimmune Case Studies
Figure 9. Tumor Case Studies
Figure 10. Others Case Studies
Figure 11. Antibody Therapeutics and Blood Antibody Therapeutics Report Years Considered
Figure 12. Global Antibody Therapeutics and Blood Antibody Therapeutics Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 13. Global Antibody Therapeutics and Blood Antibody Therapeutics Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Antibody Therapeutics and Blood Antibody Therapeutics Market Share by Region: 2023 VS 2030
Figure 15. Global Antibody Therapeutics and Blood Antibody Therapeutics Market Share by Players in 2023
Figure 16. Global Top Antibody Therapeutics and Blood Antibody Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antibody Therapeutics and Blood Antibody Therapeutics as of 2023)
Figure 17. The Top 10 and 5 Players Market Share by Antibody Therapeutics and Blood Antibody Therapeutics Revenue in 2023
Figure 18. North America Antibody Therapeutics and Blood Antibody Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 19. North America Antibody Therapeutics and Blood Antibody Therapeutics Market Share by Country (2019-2030)
Figure 20. United States Antibody Therapeutics and Blood Antibody Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Canada Antibody Therapeutics and Blood Antibody Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Antibody Therapeutics and Blood Antibody Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Antibody Therapeutics and Blood Antibody Therapeutics Market Share by Country (2019-2030)
Figure 24. Germany Antibody Therapeutics and Blood Antibody Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. France Antibody Therapeutics and Blood Antibody Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. U.K. Antibody Therapeutics and Blood Antibody Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Italy Antibody Therapeutics and Blood Antibody Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Russia Antibody Therapeutics and Blood Antibody Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Nordic Countries Antibody Therapeutics and Blood Antibody Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Antibody Therapeutics and Blood Antibody Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Antibody Therapeutics and Blood Antibody Therapeutics Market Share by Region (2019-2030)
Figure 32. China Antibody Therapeutics and Blood Antibody Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Japan Antibody Therapeutics and Blood Antibody Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. South Korea Antibody Therapeutics and Blood Antibody Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Southeast Asia Antibody Therapeutics and Blood Antibody Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. India Antibody Therapeutics and Blood Antibody Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Australia Antibody Therapeutics and Blood Antibody Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Antibody Therapeutics and Blood Antibody Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Antibody Therapeutics and Blood Antibody Therapeutics Market Share by Country (2019-2030)
Figure 40. Mexico Antibody Therapeutics and Blood Antibody Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Brazil Antibody Therapeutics and Blood Antibody Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Antibody Therapeutics and Blood Antibody Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Antibody Therapeutics and Blood Antibody Therapeutics Market Share by Country (2019-2030)
Figure 44. Turkey Antibody Therapeutics and Blood Antibody Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Saudi Arabia Antibody Therapeutics and Blood Antibody Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Roche Revenue Growth Rate in Antibody Therapeutics and Blood Antibody Therapeutics Business (2019-2024)
Figure 47. Abbvie Revenue Growth Rate in Antibody Therapeutics and Blood Antibody Therapeutics Business (2019-2024)
Figure 48. Johnson & Johnson Revenue Growth Rate in Antibody Therapeutics and Blood Antibody Therapeutics Business (2019-2024)
Figure 49. Bristol-Myers Squibb Revenue Growth Rate in Antibody Therapeutics and Blood Antibody Therapeutics Business (2019-2024)
Figure 50. Novartis Revenue Growth Rate in Antibody Therapeutics and Blood Antibody Therapeutics Business (2019-2024)
Figure 51. Merck Revenue Growth Rate in Antibody Therapeutics and Blood Antibody Therapeutics Business (2019-2024)
Figure 52. Alexion Pharmaceuticals Revenue Growth Rate in Antibody Therapeutics and Blood Antibody Therapeutics Business (2019-2024)
Figure 53. Takeda Revenue Growth Rate in Antibody Therapeutics and Blood Antibody Therapeutics Business (2019-2024)
Figure 54. Amgen Revenue Growth Rate in Antibody Therapeutics and Blood Antibody Therapeutics Business (2019-2024)
Figure 55. Biogen Revenue Growth Rate in Antibody Therapeutics and Blood Antibody Therapeutics Business (2019-2024)
Figure 56. UCB Revenue Growth Rate in Antibody Therapeutics and Blood Antibody Therapeutics Business (2019-2024)
Figure 57. Eli Lilly and Company Revenue Growth Rate in Antibody Therapeutics and Blood Antibody Therapeutics Business (2019-2024)
Figure 58. AstraZeneca Revenue Growth Rate in Antibody Therapeutics and Blood Antibody Therapeutics Business (2019-2024)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
